Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,418
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
Evaluation of the PE Coach Mobile Application Among Veterans With PTSD
for
Posttraumatic Stress Disorder
Location: Seattle WA
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 65
Code: NCT04959695
Recruiting
Pacific Northwest Udall Center (PANUC) Clinical Core
for
Parkinson Disease, Cognitive Impairment
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT01720810
Recruiting
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
for
Adenocarincoma of Pancreas, Stage III Pancreatic Cancer,
Location: Seattle WA
Sponsor: Seattle Cancer Treatment and Wellness Center
Sex: All
Age: 18 - 65
Code: NCT00323583
Phase2, Recruiting
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
for
Hypogonadism, Male, Fatigue Syndrome, Chronic
Location: Seattle WA, Boston MA
Sponsor: Seattle Institute for Biomedical and Clinical Research
Sex: Male
Age: 18 - 54
Code: NCT04049331
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
for
Multiple Myeloma, Multiple Myeloma Without Mention of Remission
Location: Seattle WA
Sponsor: All4Cure
Sex: All
Age: 18+
Code: NCT06149910
Recruiting
AIMS Cancer Outcomes Study
for
Neoplasms, Neoplasm Malignant, Advanced Cancer,
Location: Seattle WA
Sponsor: Advanced Integrative Medical Science Institute
Sex: All
Age: 0+
Code: NCT04495790
Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
for
Obesity With Diabetes, Overweight With Diabetes
Location: Seattle WA, Missoula MT, Pleasant View UT,
Sponsor: Kailera
Sex: All
Age: 18+
Code: NCT07284901
Phase3, Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Seattle WA, Portland OR, Santa Rosa CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase1, Recruiting
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
for
Acute Hepatic Porphyria
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 12+
Code: NCT04883905
Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Seattle WA, Vancouver, Edmonton, San Francisco CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase3, Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Seattle WA, Edmonton, Palo Alto CA, Los Angeles CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase3, Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
for
Severe Hypertriglyceridemia
Location: Seattle WA, Santa Clarita CA, Los Angeles CA,
Sponsor: Arrowhead Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06880770
Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma